Sucampo's Lubiprostone effective in children and adolescents

|About: Sucampo Pharmaceuticals, ... (SCMP)|By:, SA News Editor

Sucampo Pharmaceuticals' (SCMP) Lubiprostone treatment was effective and well tolerated in a trial of 127 of children and adolescents with functional constipation.

"The results of this study support lubiprostone's potential to become the first prescription treatment option available for children suffering from constipation," says Sucampo CEO Ryuji Ueno.

Sucampo now intends to initiate two Phase 3 trials of Lubiprostone. (PR)